BACKGROUND: Natural killer (NK) cells use killer immunoglobulin-like receptors (KIR) that bind to self-class I major histocompatibility complex (MHC) molecules to prevent killing of autologous cells. Mismatched allografts, which do not express recipient MHC class I molecules, can therefore be potential targets for NK-cell killing. In our living related-unrelated renal transplantation program, donor-recipient pairs vary in the amount of both HLA and KIR genes they share. This provides us with a unique opportunity to dissect the influence of KIR on NK-cell function after transplantation. METHODS: Recipient NK cells were used in a cytotoxicity assay against donor peripheral blood mononuclear cells 2 days before, on the day of, and 3 days after transplantation. Results were correlated to HLA-KIR compatibility between donor and recipient. RESULTS: NK killing, in a direct ex vivo setting, was demonstrated to be HLA mismatch dependent. Recipient NK antidonor cytotoxicity was unaltered despite having received 2 days' treatment with cyclosporine A before transplantation. However, cytotoxicity increased 3 days after transplantation in 71% of recipients. Recipients exhibiting increased NK cytotoxicity against their donors after transplantation were found to possess more activating KIR genes specific for donor class I MHC molecules than those in whom killing activity did not increase (P<0.04). CONCLUSIONS: NK cells are activated after transplantation despite quadruple immunosuppression, suggesting that recipient NK-cell cytotoxicity against the donor may be a previously unrecognized area of the rejection process, especially in poorly matched donor-recipient pairs where the recipient may not express the correct repertoire of inhibitory receptors to prevent killing of donor cells.
BACKGROUND: Natural killer (NK) cells use killer immunoglobulin-like receptors (KIR) that bind to self-class I major histocompatibility complex (MHC) molecules to prevent killing of autologous cells. Mismatched allografts, which do not express recipient MHC class I molecules, can therefore be potential targets for NK-cell killing. In our living related-unrelated renal transplantation program, donor-recipient pairs vary in the amount of both HLA and KIR genes they share. This provides us with a unique opportunity to dissect the influence of KIR on NK-cell function after transplantation. METHODS: Recipient NK cells were used in a cytotoxicity assay against donor peripheral blood mononuclear cells 2 days before, on the day of, and 3 days after transplantation. Results were correlated to HLA-KIR compatibility between donor and recipient. RESULTS: NK killing, in a direct ex vivo setting, was demonstrated to be HLA mismatch dependent. Recipient NK antidonor cytotoxicity was unaltered despite having received 2 days' treatment with cyclosporine A before transplantation. However, cytotoxicity increased 3 days after transplantation in 71% of recipients. Recipients exhibiting increased NK cytotoxicity against their donors after transplantation were found to possess more activating KIR genes specific for donor class I MHC molecules than those in whom killing activity did not increase (P<0.04). CONCLUSIONS: NK cells are activated after transplantation despite quadruple immunosuppression, suggesting that recipient NK-cell cytotoxicity against the donor may be a previously unrecognized area of the rejection process, especially in poorly matched donor-recipient pairs where the recipient may not express the correct repertoire of inhibitory receptors to prevent killing of donor cells.
Authors: J R Greenland; N P Jewell; M Gottschall; N N Trivedi; J Kukreja; S R Hays; J P Singer; J A Golden; G H Caughey Journal: Am J Transplant Date: 2014-02-11 Impact factor: 8.086
Authors: Izabela Nowak; Maria Magott-Procelewska; Agnieszka Kowal; Maciej Miazga; Marta Wagner; Wanda Niepiekło-Miniewska; Małgorzata Kamińska; Andrzej Wiśniewski; Edyta Majorczyk; Marian Klinger; Wioleta Łuszczek; Andrzej Pawlik; Rafał Płoski; Ewa Barcz; David Senitzer; Piotr Kuśnierczyk Journal: PLoS One Date: 2012-09-13 Impact factor: 3.240
Authors: Yun R Li; Jessica van Setten; Shefali S Verma; Yontao Lu; Michael V Holmes; Hui Gao; Monkol Lek; Nikhil Nair; Hareesh Chandrupatla; Baoli Chang; Konrad J Karczewski; Chanel Wong; Maede Mohebnasab; Eyas Mukhtar; Randy Phillips; Vinicius Tragante; Cuiping Hou; Laura Steel; Takesha Lee; James Garifallou; Toumy Guettouche; Hongzhi Cao; Weihua Guan; Aubree Himes; Jacob van Houten; Andrew Pasquier; Reina Yu; Elena Carrigan; Michael B Miller; David Schladt; Abdullah Akdere; Ana Gonzalez; Kelsey M Llyod; Daniel McGinn; Abhinav Gangasani; Zach Michaud; Abigail Colasacco; James Snyder; Kelly Thomas; Tiancheng Wang; Baolin Wu; Alhusain J Alzahrani; Amein K Al-Ali; Fahad A Al-Muhanna; Abdullah M Al-Rubaish; Samir Al-Mueilo; Dimitri S Monos; Barbara Murphy; Kim M Olthoff; Cisca Wijmenga; Teresa Webster; Malek Kamoun; Suganthi Balasubramanian; Matthew B Lanktree; William S Oetting; Pablo Garcia-Pavia; Daniel G MacArthur; Paul I W de Bakker; Hakon Hakonarson; Kelly A Birdwell; Pamala A Jacobson; Marylyn D Ritchie; Folkert W Asselbergs; Ajay K Israni; Abraham Shaked; Brendan J Keating Journal: Genome Med Date: 2015-10-01 Impact factor: 11.117